03.04.2012 01:05 Uhr, Quelle: Wallstreet online

NICE Fails to Grant Access to Innovative Treatment for Women With Advanced Breast Cancer, Despite Evidence That it Could Extend Their Lives

HATFIELD, England, April 3, 2012 /PRNewswire/ NICE concedes they must make corrections as toxicities were not reported appropriately for Halaven(R)Black Triangle Drug Today the National Institute for Health and Clinical Excellence (NICE) …

Weiterlesen bei Wallstreet online